• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

A Smart Way Out

Tech Letter

In a crazy turn of events, the US government is considering a national security review of Elon Musk’s Twitter (TWTR) takeover deal.

The review could potentially block the deal, saving Musk $44 billion.

I would say that Musk has been playing up this angle for quite some time.  

It’s no coincidence that he started meddling in the Russian-Ukraine dialogue just recently.

Hatching a plan to tick off the US government enough for them to decide a perceived pro-Putin supporter cannot control the reigns of the biggest public discourse forum in the world would signify a massive victory for Musk.

We know Twitter isn’t worth $44 billion.

Snap issued terrible earnings which meant the new valuation of SNAP went from $19 billion to $13 billion company in one day.

Things are so bad at SNAP that they chose to not offer guidance for the 2nd straight quarter.

Musk has also voiced how he plans to reinstate former US President Donald Trump and fire 75% of the Twitter staff on the first day on the job.

He is doing his best to “achieve” a national security review which is executed by the Committee on Foreign Investment in the US (CFIUS).

CFIUS carries out security reviews if a "transaction threatens to impair the national security of the United States," according to federal regulations.

It’s also not a shocker that Musk recently threatened to stop supplying the Starlink satellite service to Ukraine.

If Musk is perceived to not be working for Ukraine, in the political world today, this means he can be labeled a pro-Russian, pro-Putin, anti-democratic, anti-American figure worthy of tech deals getting banned.

Ironically enough, he does the dirty work for the Chinese Communist Party because he operates a gigafactory in Shanghai which produces the most Tesla’s per factory.

Musk later backed down from his threat to stop deploying Starlink and agreed to continue to suffer losses operating the service.

Musk has been providing the service for free but has said SpaceX loses $20 million a month servicing Ukraine.

I must say that Musk has a serious pathway to wriggle himself out of this $44 billion deal.

If the deal is blocked, Twitter would be valued at around $15 billion-$20 billion range, possibly $25 billion is a stretch.

It would be a devastating blow for the Twitter management and shareholders.

Management would need to change instantly because of the brand damage and loss of credibility. Musk has attacked the management and staff at Twitter non-stop throughout this process.

A major restructuring is in the cards no matter what.

Job morale at the firm is at an all-time low as Twitter employees experience depression through a threat of possible termination upon Musk’s purchase.

The fiasco is essentially what Musk wanted in the first place and I could argue that the free PR he is receiving is worth at least $100 billion from start to finish.

Musk understands the more digital footprints he plants all around the internet, the richest man in the world will get many articles published about him. Just do a Google search of Musk and he’s everywhere.

Whether it is about spaceships or social media, Musk has launched himself front and center into almost every discourse including sensitive geopolitics to solving world hunger. He even said one time he wants to buy soccer club Manchester United.

About social media tech stocks, this is highly negative news for the valuations of other social media stocks like Meta (META), but this is great news for Tesla stock if Musk doesn’t need to sell Tesla stock to pay for the Twitter deal.

Musk still needs another $10 billion in financing to cover the balance of the deal to finish the deal.

 

musk twitter

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-21 15:02:152022-11-02 04:07:06A Smart Way Out
Mad Hedge Fund Trader

October 21, 2022 - Quote of the Day

Tech Letter

“Virtual reality, all the A.I. work we do, all the robotics work we do - we're as close to realizing science fiction as it gets.” – Said CEO of Nvidia Jensen Huang

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/10/satya-nadela.png 384 342 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-21 15:00:122022-10-21 16:58:40October 21, 2022 - Quote of the Day
Mad Hedge Fund Trader

Trade Alert - (SPY) October 21, 2022 - EXPIRATION AT MAX PROFIT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-21 13:45:442022-10-21 13:45:44Trade Alert - (SPY) October 21, 2022 - EXPIRATION AT MAX PROFIT
Mad Hedge Fund Trader

Trade Alert - (META) October 21, 2022 - TAKE PROFITS - SELL

Tech Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-21 13:31:182022-10-21 13:31:18Trade Alert - (META) October 21, 2022 - TAKE PROFITS - SELL
Mad Hedge Fund Trader

Trade Alert - (TSLA) October 21, 2022 - EXPIRATION AT MAX PROFIT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-21 11:49:492022-10-21 11:49:49Trade Alert - (TSLA) October 21, 2022 - EXPIRATION AT MAX PROFIT
Mad Hedge Fund Trader

October 21, 2022

Diary, Newsletter, Summary

Global Market Comments
October 21, 2022
Fiat Lux

Featured Trade:

(OCTOBER 19 BIWEEKLY STRATEGY WEBINAR Q&A),
(BAC), (USO), (SPY), (TSLA), (NFLX), (TBT), (PLTR), (SNOW)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-21 09:04:352022-10-21 11:11:55October 21, 2022
Mad Hedge Fund Trader

October 19 Biweekly Strategy Webinar Q&A

Diary, Newsletter

Below please find subscribers’ Q&A for the October 21 Mad Hedge Fund Trader Global Strategy Webinar broadcast from Silicon Valley in California. 

Q: Bank of America (BAC) said the US consumer is strong and lending is robust. Does this mean no recession in 2023?

A: It could, because remember that while some sectors are clearly in recession, like real estate and automakers, and have been for a while, others are absolutely booming, like the airline business, and the banking business. There may not be a recession in here, or if there is one, it’s a very slight one. Count on the market to first discount a severe recession which would take the S&P 500 down to $3,000-$3,200 or so; and that’s what markets do, always overly pessimistic at the bottom and overly euphoric at tops. You can make your living off of this.

Q: What do you think about OPEC's behavior (USO) and its influence on the price of oil?

A: Clearly, they’re trying to influence the midterm elections and get an all-republican pro-oil Congress, which will be nicer to OPEC. That’s certainly what they got with the last administration and it’s safe to say that the pro-climate administration of Biden and the Saudis get along like oil and water. But long term, OPEC knows it’s going to zero, and in fact, Saudi Arabia has plans to turn their entire oil supply into hydrogen which can be exported and burned cleanly. I know the team here at UC Berkeley that’s working on that with the Saudi government. Cheap hydrogen also means airships come back, how about that? Hindenburg anyone?

Q: Will draining the Strategic Petroleum Oil Reserve (SPR) backfire, meaning deflation for the US economy and administration?

A: No, the SPR outlived its usefulness maybe 30 years ago—it’s essentially a government subsidy for Texas and Louisiana, and for the oil industry, that has taken on a life of its own. When we started the SPR in 1975, the US got more than half of its oil from the Middle East. Now, it’s almost zero. It goes to China instead. If we are a net energy producer and we have been for over 5 years, why do we even need a petroleum reserve? So no, I think we should shut it down and sell all the oil that’s in there. And it becomes even less relevant as more of the US economy turns over to alternatives.

Q: How do we operate our military with no oil?

A: The pentagon is working on a no-oil future, developing alternative fuels for all kinds of things that you wouldn’t imagine are possible. For example, instead of using diesel, jet fuel, or gasoline for our vehicles, you outfit them with electric batteries, and when the batteries go dead you just air drop new fully charged ones. It’s much better than trying to transport gasoline across the desert in a giant fuel bladder, which can be taken out by a single bullet and is what they do now. Take the pilots out of fighters and they become so light they can operate on battery power. So yes, the pentagon has actually been in the forefront of using every alternative technology they can get their hands on from the early days. Better they get them first before an enemy does.

Q: We will almost always need petroleum; far too many products use it as an ingredient.

A: That is absolutely right. Some will probably never be replaced, like asphalt, feedstock, or plastic. However, those represent less than 10% of the current oil demand. So yes, there always will be an oil industry, it just might be a heck of a lot smaller than it is now. You eliminate cars from the picture, and that’s half of all oil demand in the United States right there. And in most places in the United States, it will be illegal to sell a car that uses gasoline in 12 years. And do you make 30-year investments based on demand for your product dropping by half in 12 years? No, you don’t, which is why the oil companies themselves won’t invest in their own industries anymore. They’re only paying out profits as dividends and buying back shares, which they never used to do.

Q: Do you think the Standard & Poor’s 500 Index (SPX) $3,500 was the bottom?

A: No, we actually did get a little bit lower than that. We will be in a bottoming process over the next several months, but the pattern will be the same. Tiny marginal new bottoms, maybe 100 points lower than the last, and then these gigantic rallies. If we do make bottoms they will only be for seconds, so the way to deal with that is to only put in really low-limit orders to buy stuff, assuming 1,000 points down, and just keep entering the order every day. Eventually, you’ll get one of these throw-away fills when the algorithms panic and a bunch of market orders hit the market. That's the way to deal with that.

Q: I would say that Biden is trying to influence the elections by releasing oil reserves.

A: Absolutely he is, but then so is the oil industry, taking half of the refineries off stream 2 months before the elections, and spiking oil prices. So it’s a battle of the oil price going on here. No love lost between the oil industry and Biden, and US consumers for that matter. I don’t care if gasoline is $7 a barrel because I never buy it; I am all electric. But for a lot of working people, that’s definitely a lot of money.

Q: How concerned are you about the US going to a cashless currency?

A: I’m not worried because I pay my taxes and I don’t break any laws. If you don’t pay taxes and do break laws, like engaging in drug dealing or bribery, you should be extremely worried, as that would be the eventual goal of a cashless economy. That and the fact that the government has to spend $300 million a year printing paper money, which they’d love to get rid of. And of course, it’s cheaper for businesses to use digital currencies. Most countries in Europe don’t use physical currency anymore—it’s credit cards only.

Q: Do you expect Tesla (TSLA) to pop after earnings?

A: I have no idea; it depends on what the report says but suffice it to say that Tesla is historically cheap. It has the lowest PE multiple now than it has in the entire 13-year history of the company. Scale in on the LEAPS with Tesla—that’s what I’d be doing down here.

Q: Could the US debt situation spiral into something that gets out of hand?

A: No, because the purchasing power of debt is now deflating at an 8.4% annual rate, which means that it goes to zero in about 8.57 years. This is how the government always wins when issuing debt. It’s been going on since the French first issued government debt 300 years ago. Who pays for that? Bond investors. Anybody who owns bonds now has seen their purchasing power go up in smoke. That’s why it’s been a one-way zero bid market for two and a half years—they’ve been dumping like crazy.

Q: Should I buy debt here or sell it?

A: We’re actually getting close to a bottom in the junk debt market, which means you’re going to be yielding around 10%. That means the value of your holding doubles in 6 years, and the default rates never reach the high levels predicted by analysts in junk bonds. That has always been the key to junk bonds in the whole 50 years that I've been following this market. My neighbor up in Tahoe, Mike Milliken, made billions off that assumption.

Q: What do you think about Netflix (NFLX)?

A: Well, my advice was to buy it, to a lot of people. They’re clearly changing their business model for the better—they’re going to start picking up ad revenues, they’re cracking down on password sharing, and they delivered a 20% return in stocks. Plus their share price has just dropped down from $700 to $165. Great LEAP candidate here. 

Q: What kind of position is best if a recession hits?

A: Cash. Cash is now yielding 4.4%. The best cash alternative is 90-day T-bills issued by the US Treasury. Execution costs almost zero, and liquidity is essentially infinite; but, remember also that bull markets start 6 to 9 months before recessions end. You just have to watch your timing. Which means that if the recession ends in say July, you have to be buying stocks today. Just keep that in mind, ladies and gentleman.

Q: How do you see the futures of semis?

A: Anything you buy here now will triple in three years, but it becomes a question of how much pain you want to take in the meantime. Everyone in the investment management industry thinks the same, and it really is a classic “catch-a-falling-knife” situation— knowing that the payoff down the road is enormous. Virtually all companies are designing new semis into their products at an exponential rate.

Q: Are LEAPS part of the service?

A: Yes, they are. I will send you one tomorrow. But concierge customers get first priority because that’s what they’re paying for.

Q: How far out should we go?

A: On LEAPS, always take the maximum maturity, which is usually 2 years and 4 months. And the reason is that the second year is almost free—they charge you almost nothing for going out to maximum maturity. And if we have a recession that does last longer than people think, that extra year of maturity will be worth its weight in gold. It’ll be the difference between a zero return and a 10x return.

Q: Can we go back into the ProShares UltraShort 20+ Year Treasury (TBT)?

A: No, it would be a horrible idea to buy the (TBT) here after it just moved from $14 to $36. That’s what you buy before it goes from $14 to $36. We’re topping out in all of these short bond plays, so avoid them like the plague.

Q:  How much is the Concierge Service?

A: It’s $12,000 a year—and a bargain price at that! Almost everybody ends up covering that on their first trade, and you get an entire portfolio of LEAPS and a dedicated LEAPS website with the service. You also get my personal cell phone number so you can call me while I'm either on the beach in Hawaii or on the ski slopes of Lake Tahoe. If anyone has questions about the concierge service, contact customer support at  support@madhedgefundtrader.com.

Q: What are your thoughts on data analytics companies Snowflake (SNOW) and Palantir (PLTR)?

A: Love Snowflake, hate Palantir because the CEO isn’t interested in promoting a share price. With (SNOW), you have Warren Buffet as a major holder, so that’s all you need to know there. (SNOW) also has a 75% fall behind it.

Q: Thoughts on the Ukraine/Russia war?

A: It’ll drag on well into next year, and obviously the Iranian drones are the new factor here. I wouldn’t be surprised if there were suddenly an accident at a certain factory in Iran; that’s what happens when these things play out.

Q: Is Snowflake (SNOW) a buy right now?

A: It’s like all the rest of tech. High volatility, could have lower lows, but long-term gains are at least a triple from here. You know how much risk you can take.


To watch a replay of this webinar with all the charts, bells, whistles, and classic rock music, just log in to www.madhedgefundtrader.com, go to MY ACCOUNT, click on GLOBAL TRADING DISPATCH, then WEBINARS, and all the webinars from the last 12 years are there in all their glory.

Good Luck and Stay Healthy,

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

 

Dungeon in Montreux Castle on Lake Geneva in Switzerland

 

 

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/10/john-thomas-Montreux-Castle--e1666366030403.jpg 550 361 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-21 09:02:112022-10-21 11:12:04October 19 Biweekly Strategy Webinar Q&A
Mad Hedge Fund Trader

October 21, 2022 - Quote of the Day

Diary, Newsletter, Quote of the Day

The 40-year bull market in bonds is over,” said Dr. Jeremy Siegal of the Wharton School of Business. I agree heartily.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2020/05/dead-bear.png 243 465 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-21 09:00:342022-10-21 11:10:42October 21, 2022 - Quote of the Day
Mad Hedge Fund Trader

October 20, 2022

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
October 20, 2022
Fiat Lux

Featured Trade:

(A CURE FOR A SICKENING MARKET)
(MRK), (OGN)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-20 16:02:092022-10-20 17:29:49October 20, 2022
Mad Hedge Fund Trader

A Cure for a Sickening Market

Biotech Letter

In this sickening market, it makes sense that the biotechnology and healthcare industry is proving to be a great hedge.

This sector has managed to remain one of the handful to post gains in 2022 amidst the seemingly never-ending barrage of negative news caused by the bear market, economic and political turmoil, and even health crises.

The criteria bring me to Merck (MRK), which has performed excellently this year.

Merck is a globally dominant biopharmaceutical company, standing the test of time, and having been in operation for more than 130 years.

It has consistently delivered stable results, showing off a 28% growth in sales in the second quarter of 2022. Among the names in its roster, the most profitable drug is cancer treatment Keytruda, which recorded a 30% year-over-year growth in sales during the same period.

Despite the already remarkable performance of Keytruda, this oncology medication has proven to be capable of targeting more than just lung cancer as it was recently given the green light for 6 additional indications.

In line with ensuring the company is not reliant on a single blockbuster drug, Merck has been aggressive in seeking potential high-selling candidates to add to its portfolio.

Recently, its $11.5 billion bet on Sotatercept, a heart medication, seems to have paid off as the company disclosed positive results from a Phase 3 trial focused on treating a condition called pulmonary arterial hypertension.

It was in 2021 when Merck bought Sotatercept as part of its agreement to acquire Accelerant Pharma. The goal was to find a drug to fill the anticipated revenue gap from the impending patent loss of Keytruda by 2030.

The strategy was high risk at that time because data on Sotatercept were limited on Phase 2 trial results. Nevertheless, Merck paid a significant sum to the company. That was reported as one of the biggest acquisitions of 2021.

Given the current data, the conservative estimate for Sotatercept sales is at $700 million annually. However, the established nature of the target market has some analysts pushing the forecast to potentially reach $4 billion by 2031.

However, unlike other biopharmaceutical companies that heavily depend on one or two blockbuster treatments, Merck has a strong lineup of high-margin products in the market.

Moreover, its pipeline candidates support its solid profitability and investment capital returns for several years. This becomes even more apparent with the spinoff of Organon (OGN) in 2021, where Merck retained a portfolio of drugs with strong patent protection.

It holds a moat-worthy portfolio of specialty treatments in various sectors, including oncology, immunology, cardiometabolic disease, rare diseases, and infections. It also has an extensive vaccine segment that targets HPV, pediatric conditions, shingles, and Hepatitis B.

In the past trailing 12 months, the company generated roughly $57 billion in revenue, with half coming from US sales and the rest internationally.

More importantly, Merck sports a notable 3.1% dividend yield that’s easily supported by a low 35% payout ratio. It reports a 9% five-year CAGR and has an impressive 11-year growth streak.

Throughout the years, Merck’s stock, underlying strategies, and growth model have demonstrated their resilience against macroeconomic headwinds, with the company’s core businesses firing on all cylinders.

It has one of the most solid balance sheets in the industry, which illustrates its financial flexibility to comfortably invest in promising R&D prospects and sustain its dividend at a solid pace.

Overall, Merck is an excellent choice for investors looking to deploy some capital but want to minimize exposure to volatility on top of the possibility of earning some extra dividend income.

 

merck

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-10-20 16:00:092022-11-02 03:45:43A Cure for a Sickening Market
Page 5 of 18«‹34567›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top